[ WISE s.r.l raises $7.29M in Series B ]
WISE s.r.l has raised $7.29 million in Series B funding.
Founded in 2011, Wise s.r.l is a medical device company developing next-generation implantable neuromodulation. It develops novel, highly flexible and stretchable implantable neuromodulation leads for the treatment of a range of neurological conditions based on its proprietary Supersonic Cluster Beam Implantation technology.
By means of the new financial round, WISE aims to market its first product for acute use, Cortical Electrodes for intraoperative monitoring, and to conclude the development of its breakthrough product, the first percutaneously-implantable paddle lead for Spinal Cord Stimulation.
|Founder / CEO||Luca Ravagnan|
|Previous Investors||btov Partners|